News for Healthier Living

Seeing the Invisible: Minimal Residual Disease Opens a New Window in Breast Cancer Care

Breast cancer relapse often begins long before it can be seen. Tiny clusters of residual tumor cells may persist after treatment, quietly driving recurrence while remaining invisible to conventional imaging. This review highlights how minimal residual disease (MRD), detected through circulating tumor DNA (ctDNA) in blood, is changing that reality.

December 29, 2025


January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025